Autopsy report · NCT06222398

Exoskeleton Use With In Home Functional Activities

“We have finished all data collection for phase I and are not ready to start phase II”

The sponsor’s own words in the registry.

Life of this trial

• Registered 2 months before it started.
• Ran for about 1 year 11 months before it stopped.
• 12 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Sponsor

A.T. Still University of Health Sciences

Sponsor type

University, hospital or other

Conditions

Paraplegia

Interventions

Exoskeleton

Participants

12

Sites

1

Countries

United States

Trials that died the same way

• Imatinib in Combination With Dacarbazine and Capecitabine in Medullary Thyroid Carcinoma
  “Study closed following Phase I portion, insufficient activity to continue to Phase II.” (58% match in meaning)
• Five Fraction SABR Dose Escalation for Early Stage Squamous Cell Carcinoma of the Lung
  “After completion of Phase I, it was decided not to initiate Phase II of the study.” (56% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.